Laboratorio Reig Jofre SA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Laboratorio Reig Jofre SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014102
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Laboratorio Reig Jofre SA (Reig Jofre) is a drug company that develops and manufactures medicinal products and nutritional supplements. The company’s product categories include specialized technology products, specialty therapeutic areas, and nutritional supplements and consumer healthcare. Its specialized technology products include antibiotics, injectable, and freeze-dried products. Reig Jofre develops products in liquid dosage forms, semi-solid forms, and solid oral dosage forms. The company offers services such as research and development, regulatory services, manufacturing, and licensing of dossiers. It conducts research in the areas of bioequivalence, clinical pharmacokinetics and bioavailability studies, drug interaction, preclinical pharmacokinetics, preclinical toxicokinetics, analysis and identification of metabolites. The company offers therapeutic products in the areas of dermatology, gynecology, and respiratory. Reig Jofre is headquartered in Sant Joan Despi, Spain.

Laboratorio Reig Jofre SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Laboratorio Reig Jofre SA, Medical Devices Deals, 2011 to YTD 2017 9
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Laboratorio Reig Jofre Acquires Right for Heparin Sodium in Spain from Chiesi Espana 11
Laboratorio Reig Jofre Acquires Product Licenses from Dema UK for USD5.4 Million 12
Partnerships 13
Reig Jofre Enters Into Co-Development Agreement With Ojer Pharma For Nobactine 13
Merger 14
Laboratorio Reig Jofre Merges with Natraceutical 14
Licensing Agreements 15
Laboratorio Reig Jofre Enters into Licensing Agreement with Church & Dwight 15
Acquisition 16
Laboratorio Reig Jofre Acquires Remaining 50% Stake in Geadic Biotec for USD2.5 Million 16
Laboratorio Reig Jofre SA – Key Competitors 17
Laboratorio Reig Jofre SA – Key Employees 18
Laboratorio Reig Jofre SA – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 20
Recent Developments 21
Financial Announcements 21
Aug 01, 2017: Reig Jofre: Results of First Half 2017 21
May 09, 2017: Reig Jofre: Results for the First Quarter of 2017 23
Jul 26, 2016: Reig Jofre: Results of First Half 2016 25
Product News 28
Sep 13, 2017: Reig Jofre Continues to Strengthen its Leadership in ENT with the Launch Of Otospray, 3E Ear Hygiene 28
Mar 23, 2017: Reig Jofre Starts Marketing of three New Injectable Products fror Hospitals 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Key Facts 2
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Laboratorio Reig Jofre SA, Deals By Therapy Area, 2011 to YTD 2017 8
Laboratorio Reig Jofre SA, Medical Devices Deals, 2011 to YTD 2017 9
Laboratorio Reig Jofre SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Laboratorio Reig Jofre Acquires Right for Heparin Sodium in Spain from Chiesi Espana 11
Laboratorio Reig Jofre Acquires Product Licenses from Dema UK for USD5.4 Million 12
Reig Jofre Enters Into Co-Development Agreement With Ojer Pharma For Nobactine 13
Laboratorio Reig Jofre Merges with Natraceutical 14
Laboratorio Reig Jofre Enters into Licensing Agreement with Church & Dwight 15
Laboratorio Reig Jofre Acquires Remaining 50% Stake in Geadic Biotec for USD2.5 Million 16
Laboratorio Reig Jofre SA, Key Competitors 17
Laboratorio Reig Jofre SA, Key Employees 18
Laboratorio Reig Jofre SA, Other Locations 19
Laboratorio Reig Jofre SA, Subsidiaries 19
Laboratorio Reig Jofre SA, Joint Venture 20

★海外企業調査レポート[Laboratorio Reig Jofre SA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SQI Diagnostics Inc (SQD):企業の財務・戦略的SWOT分析
    Summary SQI Diagnostics Inc (SQI Diagnostics) is a diagnostic company that provides in vitro diagnostic and pharmaceutical research products. The company provides products such as sqidworks, sqidlite and sqid-X. Its sqidworks system is used in labs. SQI Diagnostic’s sqidlite is a practical benchtop …
  • Antibe Therapeutics Inc (ATE):企業の財務・戦略的SWOT分析
    Summary Antibe Therapeutics Inc (Antibe) is a biotech company that designs and develops drug candidates for chronic pain and inflammation; and regenerative medicine. The company discovers and commercializes novel drugs, biologics and medical devices. It offers lead compound ATB-346, a naproxen deriv …
  • Ten Network Holdings Ltd:企業の戦略的SWOT分析
    Ten Network Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • NanoString Technologies Inc (NSTG):企業の財務・戦略的SWOT分析
    Summary NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics. The company's products include sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion pane …
  • Aradigm Corp (ARDM):医療機器:M&Aディール及び事業提携情報
    Summary Aradigm Corp (Aradigm) is a specialty pharmaceutical company that develops and commercializes inhalation drugs for the prevention and treatment of severe respiratory diseases. The company's product pipeline includes Pulmaquin (ARD-3150) and Lipoquin (ARD-3100) for the treatment of non-cystic …
  • Genetic Signatures Ltd (GSS):企業の製品パイプライン分析
    Summary Genetic Signatures Ltd (Genetic Signatures) formerly Human Genetic Signatures Pty Ltd, is a molecular diagnostics company. The company designs and manufactures real-time polymerase chain reaction (PCR) based products for the detection of infectious diseases under the EasyScreen brand. It off …
  • Janus Henderson Group Plc:企業の戦略・SWOT・財務情報
    Janus Henderson Group Plc - Strategy, SWOT and Corporate Finance Report Summary Janus Henderson Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • KYORIN Holdings Inc (4569):製薬・医療:M&Aディール及び事業提携情報
    Summary KYORIN Holdings Inc (KYORIN), formerly known as KYORIN Co.,Ltd., is a holding company. Its business activities include controlling, administering and supporting companies, which conduct various businesses by holding the shares of those companies. The company through its subsidiaries carries …
  • Asahi Group Holdings Ltd:戦略・SWOT・企業財務分析
    Asahi Group Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Asahi Group Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Thai Oil Public Co Ltd (TOP):企業の財務・戦略的SWOT分析
    Thai Oil Public Co Ltd (TOP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Weyerhaeuser Company:企業の戦略・SWOT・財務情報
    Weyerhaeuser Company - Strategy, SWOT and Corporate Finance Report Summary Weyerhaeuser Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • MOL Hungarian Oil and Gas PLC (MOL):石油・ガス:M&Aディール及び事業提携情報
    Summary MOL Hungarian Oil and Gas PLC (MOL) is an integrated oil and gas company. It explores for, develops and produces crude oil, natural gas and other gas products. The company refines, transports and stores crude oil; markets crude oil products on wholesale and retail basis, and produces and sel …
  • Johnson Matthey Plc (JMAT):企業の財務・戦略的SWOT分析
    Johnson Matthey Plc (JMAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • CMA CGM SA:戦略・SWOT・企業財務分析
    CMA CGM SA - Strategy, SWOT and Corporate Finance Report Summary CMA CGM SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Marathon Oil Corp (MRO):石油・ガス:M&Aディール及び事業提携情報
    Summary Marathon Oil Corp (MRO) is independent energy company, which explores, produces and markets liquid hydrocarbons and natural gas. It focuses mainly on unconventional resource plays in the US with operations in Africa and Europe. The company has properties in the major oil-rich resource plays …
  • Hess Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Hess Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Hess Corp (Hess) is a global independent energy company which carries out the exploration and production of crude oil and natural gas. It primarily operates in US, Denmark, the Joint Development Area of Ma …
  • NetSol Technologies, Inc. (NTWK):企業の財務・戦略的SWOT分析
    NetSol Technologies, Inc. (NTWK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Global Petroleum Ltd (GBP):石油・ガス:M&Aディール及び事業提携情報
    Summary Global Petroleum Ltd (Global Petroleum) is an oil and gas company that offers oil and gas exploration and development services. The company operates through a portfolio of oil and gas projects in offshore Namibia and others. Its Namibian Project is into petroleum and gas exploration and Juan …
  • Bilfinger Tebodin BV:企業の戦略的SWOT分析
    Bilfinger Tebodin BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Compumedics Ltd (CMP):企業の財務・戦略的SWOT分析
    Summary Compumedics Ltd (Compumedics) is a medical device company. It develops and commercializes computer-based medical products. The company designs, develops and commercializes computer aided medical diagnostic systems. It provides product categories such as sleep diagnostics, neurology diagnosti …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆